Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation

Published:2009-07 Issue:7 Volume:19 Page:457-465
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Blier Pierre,Gobbi Gabriella,Turcotte Julie E.,de Montigny Claude,Boucher Nathalie,Hébert Chantal,Debonnel Guy

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference31 articles.

1. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials;Ballesteros;J. Affect. Disord.,2004

2. Mirtazapine compared with paroxetine in major depression;Benkert;J. Clin. Psychiat.,2000

3. Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain;Besson;Eur Neuropsychopharmacol.,2000

4. Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors;Bergeron;Am. J. Psychiat.,1994

5. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine;Carpenter;Biol.Psychiat.,2002

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024;L'Encéphale;2024-02

2. Sertraline with desvenlafaxine and sertraline with mirtazapine as treatment initiation in MDD patients with moderate to severe depression and effect on inflammatory markers;International Journal of Psychiatry in Clinical Practice;2023-11-29

3. Antidepressivakombinationen in der Akuttherapie der Depression;NeuroTransmitter;2023-11

4. RE: A case of treatment-resistant depression in an older adult and a discussion of treatment options;BJPsych Bulletin;2023-05-26

5. Rethinking the medication management of major depression;Expert Review of Neurotherapeutics;2023-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3